Jean-Louis Vincent. The Lancet Infectious Diseases, Early Online Publication, 1 December 2010
Infections caused by multidrug-resistant bacteria (MRB) are undoubtedly associated with higher morbidity and mortality and greater costs than are other infections. 1—4 Patients with MRB infections are more seriously ill than are patients infected with antibiotic-susceptible bacteria, and have higher severity scores and longer hospital stays. These patients typically have also received recent antibiotic therapy and many have some degree of immunosuppression. Therefore, that infection related to MRB ...

Weblink here